N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases
摘要:
A family of thieno[3,2-b]pyridine based small molecule inhibitors of c-Met and VEGFR2 were designed based on lead structure 2. These compounds were shown to have IC50 values in the low nanomolar range in vitro and were efficacious in human tumor xenograft models in mice in vivo. (C) 2009 Elsevier Ltd. All rights reserved.
一种简单的一锅多步级联反应,可以提供一系列对映体(最高ee为98%)的取代的苯并[ d ]吡啶并[2,1- b ]恶唑烷和[1,3]恶嗪衍生物。已经开发了非对映选择性(4:1至> 20:1 dr)的方法,通常具有良好的优良收率(高达99%)。这种精心设计的策略可在温和条件下以简单的操作应用于多种基材。
Enantioselective Organocatalytic Synthesis of Oxazolidine Derivatives through a One-Pot Cascade Reaction
作者:Zhichao Jin、Huicai Huang、Wenjun Li、Xiaoyan Luo、Xinmiao Liang、Jinxing Ye
DOI:10.1002/adsc.201000647
日期:2011.2.11
An asymmetric organocatalytic cascade reaction which can afford a series of oxazolidine derivatives has been developed. The one-pot reaction reported here can produce an oxazolidine derivative in a highly enantioselective manner and good yield with good to excellent diastereomeric ratio.
Diastereo- and Enantioselective Synthesis of Oxazine and Oxazolidine Derivatives with a Chiral Quaternary Carbon Center under Multifunctional Catalysis
作者:Zhichao Jin、Xiao Wang、Huicai Huang、Xinmiao Liang、Jinxing Ye
DOI:10.1021/ol102643a
日期:2011.2.18
An easy one-pot, multistep cascade reaction which could afford a series of substitutedbenzo[d]pyrido[2,1-b]oxazolidine and [1,3]oxazine derivatives in a highly enantio- (up to 98% ee) and diastereoselective (4:1 to >20:1 dr) manner with generally good to excellent yields (up to 99%) has been developed. This well designed strategy could be applied to a wide scope of substrates under mild conditions
一种简单的一锅多步级联反应,可以提供一系列对映体(最高ee为98%)的取代的苯并[ d ]吡啶并[2,1- b ]恶唑烷和[1,3]恶嗪衍生物。已经开发了非对映选择性(4:1至> 20:1 dr)的方法,通常具有良好的优良收率(高达99%)。这种精心设计的策略可在温和条件下以简单的操作应用于多种基材。
N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases
A family of thieno[3,2-b]pyridine based small molecule inhibitors of c-Met and VEGFR2 were designed based on lead structure 2. These compounds were shown to have IC50 values in the low nanomolar range in vitro and were efficacious in human tumor xenograft models in mice in vivo. (C) 2009 Elsevier Ltd. All rights reserved.